Order results by:
| Issue | Title | |
| Vol 15, No 2 (2022) | Epigenetic aspects in rehabilitation of female cancer patients | Abstract similar documents |
| A. G. Solopova, D. V. Blinov, S. V. Demyanov, G. V. Demyanov, E. E. Achkasov, A. Yu. Vlasina, L. N. Sandzhieva, D. M. Ampilogova | ||
| "... The influence of epigenetic processes on the development of malignant diseases, including ..." | ||
| Vol 15, No 1 (2022) | Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, A. N. Plutnitskiy, D. M. Ampilogova, L. N. Sandzhieva, D. I. Korabel’nikov, D. A. Petrenko | ||
| "... During the past decades, the prevalence of cancer diseases of female reproductive system has been ..." | ||
| Vol 16, No 2 (2023) | Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko | ||
| "... Patients who underwent radical antitumor treatment for ovarian cancer, borderline ovarian tumors ..." | ||
| Vol 18, No 2 (2025) | Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer | Abstract similar documents |
| O. S. Gridasova, A. G. Solopova, E. I. Rumyantseva, A. E. Ivanov, D. О. Utkin, J. Kh. Khizroeva | ||
| "... cancer presents challenges. Treatment options for VVA, the genital manifestation of the genitourinary ..." | ||
| Vol 15, No 4 (2022) | Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction | Abstract similar documents |
| D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko | ||
| "... cancer, is a characteristic trend of the 21st century. Part of them receive menopausal hormone therapy ..." | ||
| Vol 12, No 4 (2019) | Crucial areas of the economic analysis of public cancer care | Abstract similar documents |
| D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova | ||
| "... Introduction. The economic aspects of providing cancer care to the public attract increasing ..." | ||
| Vol 17, No 2 (2024) | The effectiveness of rehabilitation in vulvovaginal atrophy | Abstract similar documents |
| D. М. Ampilogova, А. G. Solopova, D. V. Blinov, А. Е. Ivanov, S. V. Khlopkova, G. К. Bykovshchenko | ||
| "... ВВА были распределены в группы получавших комплексную «активную» реабилитацию (группа 1А ..." | ||
| Vol 15, No 2 (2022) | Strengthening medical rehabilitation services in health system: a situation analysis | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, L. N. Sandzhieva, E. E. Achkasov, D. I. Korabelnikov, D. M. Ampilogova, S. M. Khlopkova | ||
| "... Цель: оценить эффективность изменений в нормативной базе, регулирующих медицинскую реабилитацию ..." | ||
| Vol 7, No 3 (2014) | PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY | Abstract similar documents |
| V. S. Dombrovskiy, V. V. Omelyanovskiy | ||
| "... критериев оценки программ реабилитации больных, перенесших инсульт, черепноозговую травму или другие ..." | ||
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract similar documents |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| Vol 15, No 1 (2022) | Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova | ||
| "... вмешательства. Подготовка к эндопротезированию и реабилитация после операции обычно предусматривает меры по ..." | ||
| Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER | Abstract similar documents |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| "... it was determined that for 10-years horizon cost rate for the treatment of one patient with breast cancer will be 1 ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer | Abstract similar documents |
| Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova | ||
| "... for metastatic colorectal cancer (mCRC) based on real practical data on medical help for patients ..." | ||
| Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
| A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
| "... of hospitalization (case reports) of 214 colorectal cancer patients treated with oxaliplatin at the St. Petersburg ..." | ||
| Vol 10, No 2 (2017) | PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY | Abstract similar documents |
| A. V. Rudakova, S. A. Protsenko, I. A. Koroleva | ||
| "... Treatment of patients with non-small-cell lung cancer (NSCLC) is one of important problems ..." | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation | Abstract similar documents |
| M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova | ||
| "... 2+) breast cancer who receive neoadjuvant “docetaxel / carboplatin / trastuzumab + pertuzumab ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract similar documents |
| D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
| "... for stage IV non-small-cell lung cancer with oral vinorelbine and pemetrexed as well as first-line ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..." | ||
| Vol 11, No 2 (2018) | Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer | Abstract similar documents |
| G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin | ||
| "... Breast cancer remains the most common malignant neoplasm in women. According to the current ..." | ||
| Vol 12, No 1 (2019) | Efficacy of photodynamic therapy in treatment of adult patients with skin cancer | Abstract similar documents |
| O. V. Kirsanova | ||
| "... Photodynamic therapy (PDT) is a relatively new non-surgical treatment for cancer and precancerous ..." | ||
| Vol 9, No 2 (2016) | METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY | Abstract similar documents |
| N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov | ||
| "... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..." | ||
| Vol 11, No 4 (2018) | Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer | Abstract similar documents |
| N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov | ||
| "... , became available for treatment of metastatic castration-resistant prostate cancer (mCRPC). enzalutamide ..." | ||
| Vol 13, No 3 (2020) | Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 | Abstract similar documents |
| A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina | ||
| Vol 18, No 1 (2025) | Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms | Abstract similar documents |
| A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya | ||
| "... thrombosis in cancer patients, partly due to their inability to consider the individual characteristics ..." | ||
| Vol 8, No 2 (2015) | CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER | Abstract similar documents |
| Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov | ||
| "... of venous access in the treatment of children with cancer. Objective: to conduct clinical and economic ..." | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... radio iodine refractory differentiated thyroid cancer in the Russian Federation. Methods. Cost ..." | ||
| Vol 10, No 1 (2017) | EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... aspects) drug for the treatment of widespread progressing differentiated thyroid cancer (DTC) refractory ..." | ||
| Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract similar documents |
| N. K. Mazina, P. V. Mazin | ||
| "... Recently, an increase in the incidence of severe forms of prostate cancer, in particular ..." | ||
| Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
| D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
| "... Background. Prediction of breast cancer (BC) progression is important for the timely correction ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer | Abstract similar documents |
| O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova | ||
| "... on the analysis of its cost and effectiveness in patients with chronic pain syndrome in pancreatic cancer ..." | ||
| Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
| "... Background. The therapy of chronic pain in cancer patients is a highly topical issue ..." | ||
| Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
| "... cancer (NSCLC). Materials and methods. The calculations included the direct costs of the healthcare ..." | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract similar documents |
| E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
| "... in treatment planning for early breast cancer and allows to avoid immediate and long-term complications ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER | Abstract similar documents |
| A. U. Kulikov | ||
| "... Abstract: lung cancer takes the second place in the general structure of incidence of malignant ..." | ||
| Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
| N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
| Vol 17, No 1 (2024) | STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract similar documents |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
| "... with advanced small cell lung cancer (SCLC), but with the advent of new immunological drugs, immune checkpoint ..." | ||
| Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract similar documents |
| S. K. Zyryanov, I. N. Dyakov | ||
| "... death protein 1 (PD-1)) in patients with advanced non-small cell lung cancer (NSCLC) after previous ..." | ||
| Vol 17, No 1 (2024) | Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... patients with non-small cell lung cancer (NSCLC) in the first line of therapy. Material and methods ..." | ||
| Vol 7, No 4 (2014) | MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES | Abstract similar documents |
| M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya | ||
| "... неврологическом стационаре с последующим переводом его в отделение медицинской реабилитации. При выполнении ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| "... OR chondroitin OR ((“Collagen Type II” OR “type II collagen”) AND pharmacology)) AND (Cancer OR cancers OR tumor ..." | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... and the availability of effective medical care. The current approach of access to cancer medicines limits ..." | ||
| Vol 16, No 1 (2023) | Modern biomarkers of acute kidney injury | Abstract similar documents |
| D. I. Korabelnikov, M. O. Magomedaliev | ||
| "... влияние на медико-экономические аспекты лечения и реабилитации. Обзор литературы позволяет сделать выводы ..." | ||
| Vol 14, No 4 (2021) | Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy | Abstract similar documents |
| I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova | ||
| "... эндотелиопатии. Регенерация эндотелия особенно актуальна в реабилитации пациентов, переболевших COVID-19. ..." | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| "... медицинские затраты (диагностика, лекарственное и хирургическое лечение, реабилитация), прямые немедицинские ..." | ||
| Vol 11, No 1 (2018) | Options to optimize the access to biosimilars: analysis and solutions | Abstract similar documents |
| O. V. Kirsanova, V. V. Omelyanovsky | ||
| "... , including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction ..." | ||
| Vol 9, No 1 (2016) | COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA | Abstract similar documents |
| G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy | ||
| "... comparison were: bevacizumab for metastatic renal cell carcinoma, eribulin for metastatic breast cancer ..." | ||
| Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
| D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
| "... describes the functioning of the DRG model in 2018 and the payment for cancer care and also provides ..." | ||
| Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
| "... реабилитации пациентов с COVID-19 и другими респираторными вирусными инфекциями. Заключение. Биофлавоноиды и ..." | ||
| Vol 16, No 1 (2023) | Clinical approbation today: analysis of current problems and solutions | Abstract similar documents |
| V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva | ||
| "... клинической апробации (КА) методов профилактики, диагностики, лечения и реабилитации для оптимизации системы ..." | ||
| 1 - 50 of 60 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
